Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Argus Health
Chubb
AstraZeneca
Johnson and Johnson
Express Scripts
Deloitte
Moodys
US Army

Generated: June 21, 2018

DrugPatentWatch Database Preview

LEVOBUNOLOL HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Summary for LEVOBUNOLOL HYDROCHLORIDE
Drug patent expirations by year for LEVOBUNOLOL HYDROCHLORIDE
Pharmacology for LEVOBUNOLOL HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for LEVOBUNOLOL HYDROCHLORIDE
Synonyms for LEVOBUNOLOL HYDROCHLORIDE
( inverted exclamation markA)-Bunolol Hydrochloride
(-) -Levobunolol hydrochloride
(-)-3,4-Dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-1(2H)-naphthalenone hydrochloride
(-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone hydrochloride
(-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalene-1(2H)-one hydrochloride
(+-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone hydrochloride
(+) -Levobunolol hydrochloride
(+)-Bunolol Hydrochloride
(2S)-N-(tert-butyl)-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride
(R-Bunolol Hydrochloride)""
(R)-5-[3-(tert-Butylamino)-2-hydroxypropoxy]-3,4-dihydro- 1(2H)-naphthalenone Hydrochloride
1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride, (-)-
1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride,(-)-
1(2H)-Naphthalenone, 5-((2R)-3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride (1:1)
1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)-
1(2H)-Naphthalenone, 5-(3-(1,1-dimethylethyl)amino)-2-(hydroxypropoxy)-3,4-dihydro-, hydrochloride (+-)
1(2H)-Naphthalenone, 5-(3-(1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride (+-)
27867-05-6
27912-14-7
2L31MJM4SE
31969-05-8
47141-42-4 (acid)
5-({(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride
5-[(2R)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride
5-[(2R)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone Hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one hydrochloride
5-[(2S)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone
5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride
5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2h)-one hydrochloride(1:1)
5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone Hydrochloride
5-{[(2R)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydro-1(2H)-naphthalenone hydrochloride
5-{[3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one hydrochloride
AC-1117
AC1L2A6D
AC1NR4EJ
AC1O4WIS
AC1Q3EOH
ACM27867056
ACM31969058
AG-901
AGN-101291-A-L
Akbeta
AKOS025401339
AKOS030242219
AKOS030526127
AN-15275
API0003157
API0010884
Betagan
Betagan (TN)
BetaSite
Bunolol HCl
Bunolol hydrochloride
Bunolol hydrochloride (USAN)
Bunolol hydrochloride [USAN]
Bunolol Hydrochloride 1.0 mg/ml in Methanol (as free base)
Bunolol hydrochloride, (+)-
C17H25NO3.HCl
CAS-27912-14-7
CCG-213481
CCG-220847
CCG-220857
CCRIS 1062
CHEBI:6439
CHEMBL1201177
CHEMBL1704116
CHEMBL2106021
CS-4554
CTK7J6806
CTK8F9458
CTK8G0556
d-Bunolol Hydrochloride
D01025
D03177
Dextrobunolol hydrochloride
dl-Bunolol Hydrochloride
DNTDOBSIBZKFCP-YDALLXLXSA-N
DSSTox_CID_777
DSSTox_GSID_20777
DSSTox_RID_75784
DTXSID6020777
DTXSID90423567
EINECS 248-725-3
ENT-LEVOBUNOLOL HYDROCHLORIDE
ent-Levobunolol Hydrochloride (R-Bunolol Hydrochloride)
ent-Levobunolol Hydrochloride (R-Bunolol Hydrochloride)
ent-Levobunolol, Hydrochloride
ent-Levobunolol,Hydrochloride
FT-0663908
FT-0670772
Gotensin
HMS1570J15
HMS1570L15
HY-B1035
J-016904
l-Bunolol
l-Bunolol hydrochloride
Levobunolol (hydrochloride)
Levobunolol HCl
Levobunolol hydrochloride (JAN/USP)
Levobunolol hydrochloride [USAN]
levobunolol monohydrochloride
Levobunolol, Hydrochloride
Levobunolol.HCl
LS-174362
LS-7472
Mirol
MLS002154030
MLS002154036
MolPort-003-848-379
NCGC00016801-01
NCGC00016801-05
NSC-759158
NSC759158
O90S49LDHH
OR252100
Pharmakon1600-01505551
Prestwick_1033
Prestwick_167
rac-Bunolol Hydrochloride
SCHEMBL42262
SCHEMBL613150
SMR001233357
SMR001233363
SR-05000001735
SR-05000001735-5
Tox21_110617
Tox21_110617_1
UNII-2L31MJM4SE
UNII-O90S49LDHH
UNII-W0Q9J8634Z component DNTDOBSIBZKFCP-UTONKHPSSA-N
UNII-W0Q9J8634Z component DNTDOBSIBZKFCP-YDALLXLXSA-N
VA11166
Vistagan
W 6412A
W 6421A
W 7000A
W-7000A

US Patents and Regulatory Information for LEVOBUNOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074851-001 Oct 28, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074307-001 Mar 4, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075473-001 Aug 3, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075475-001 Aug 3, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Queensland Health
Merck
US Army
Cipla
QuintilesIMS
Teva
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.